Phase 1 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men, or women who are not pregnant and not breastfeeding, between 18 and 55 years old
- People with a body mass index (a measure of body weight relative to height) between 25.0 and 35.0, and who weigh at least 50 kg
Who may not be able to join:
- People with a history of any significant illness or health condition
- People with a history of, or current significant problems with the heart, kidneys, liver, skin, lungs, nervous system, mental health, or digestive system, including a history of pancreatitis (inflammation of the pancreas) or gallstones
- People who have had a significant illness, medical procedure, or surgery in the 4 weeks before the first planned dose
- People with abnormal blood chemistry, blood cell counts, clotting, or urine test results that are considered clinically significant
- People with abnormal readings for vital signs such as blood pressure, heart rate, or temperature that are considered clinically significant
- People with abnormal results on a heart tracing test (ECG) that are considered clinically significant
- People with a blood sugar marker (HbA1c) at or above 6.5%, which can indicate diabetes or pre-diabetes
- People who show signs of reduced kidney function
- Women who are pregnant or breastfeeding
- People who have taken a medication containing an amylin analogue (a type of hormone-related drug) within the last 30 days, or within 5 half-lives of that drug — whichever is the longer period (confirm with trial site)
- People who have previously received the study drug AZD6234
- People who are currently taking any prescribed or non-prescribed medications
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximum observed plasma concentration (Cmax); Area under the concentration-time curve from time 0 to the time of the last measurable concentration (AUC0-t); Area under the concentration-time curve from time 0 extrapolated to infinity (AUC0-inf)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.